Go Pro

AgomAb Therapeutics (AGMB) Earnings Date, Estimates & Call Transcripts

AgomAb Therapeutics logo
$13.22 -0.72 (-5.16%)
Closing price 04:00 PM Eastern
Extended Trading
$13.34 +0.13 (+0.95%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AgomAb Therapeutics Earnings Summary

AgomAb Therapeutics issued Q2 2026 earnings on August 6, 2026, reporting an EPS of -$0.46. With a trailing EPS of $0.00, AgomAb Therapeutics' earnings are expected to decrease next year, from ($1.74) to ($2.08) per share.

Get AgomAb Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on AgomAb Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AgomAb Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$0.39-$0.39-$0.39
Q2 20261-$0.37-$0.37-$0.37
Q3 20261-$0.56-$0.56-$0.56
Q4 20261-$0.46-$0.46-$0.46

AgomAb Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026--$0.4550--$0.4550--

AgomAb Therapeutics Earnings - Frequently Asked Questions

AgomAb Therapeutics (NASDAQ:AGMB) last announced its quarterly earning data on Thursday, August 6, 2026. Learn more on AGMB's earnings history.

AgomAb Therapeutics (NASDAQ:AGMB) has a recorded net income of -$70.77 million. AGMB has generated $0.00 earnings per share over the last four quarters.

AgomAb Therapeutics' earnings are expected to decrease from ($1.74) per share to ($2.08) per share in the next year.


Earnings data for NASDAQ:AGMB is sourced from Fiscal.ai, with the most recent quarter reported on 8/6/2026. New results are added as companies report their earnings.
From Our Partners